ARTICLE | Company News
Dendreon, U.S. Department of Veterans Affairs cancer news
September 24, 2012 7:00 AM UTC
Dendreon received an $8 million contract from the VA to provide Provenge sipuleucel-T to treat prostate cancer patients in the VA hospital system. Dendreon declined to disclose details, while the VA ...